Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-03 · accession 0001415889-23-004182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | 2023-03-03 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.40 | +4,166 | 34.2K | +14% | +$9,998 | |
| 2023-03-03 | 2023-03-03 | FENC | RALLIS CHRIS A | Dir | F - Tax | $9.09 | -2,177 | 32.1K | -6% | -$19.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-03-03 | M | A | 4,166 | $2.40 | 34,184 | D | — | — | (F1) Represents options granted April 3, 2013, with a $2.40 USD strike price and expiration of April 3, 2023. |
| 2 | Common | Common Shares | 2023-03-03 | F | D | 2,177 | $9.09 | 32,077 | D | — | — | (F2) Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,166 shares from an April 3, 2013 grant. |